What is the probability of a 12‑mm kidney stone passing with medical expulsive therapy in an adult with normal renal function and no urinary infection or anatomic abnormalities?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Likelihood of Spontaneous Passage for a 12mm Renal Stone

A 12mm kidney stone has an extremely low probability of spontaneous passage with medical management and requires surgical intervention. The American Urological Association guidelines clearly state that medical expulsive therapy and observation are only appropriate for stones ≤10mm, and stones >10mm require surgical management 1.

Stone Size and Passage Rates

The evidence demonstrates a clear inverse relationship between stone size and spontaneous passage probability:

  • Stones ≤5mm: 68% spontaneous passage rate (95% CI: 46-85%) 2, 3
  • Stones 5-10mm: 47% spontaneous passage rate (95% CI: 36-59%) 2, 3
  • Stones >10mm: Spontaneous passage is unlikely and not adequately studied because surgical intervention is standard 3, 4

For your 12mm stone specifically, the spontaneous passage rate approaches near-zero, as this exceeds the size threshold where conservative management is evidence-based 1.

Why Medical Management Fails for 12mm Stones

The AUA/EAU guidelines explicitly recommend against conservative management for stones >10mm because 1:

  • The stone diameter exceeds the physiologic capacity of the ureter to dilate sufficiently for passage
  • Medical expulsive therapy with alpha-blockers (which increases passage rates by 29% for smaller stones) has only been studied and proven effective for stones <10mm 1, 3
  • The meta-analysis showing 77.3% stone-free rates with alpha-blockers versus 54.4% with placebo specifically excluded stones >10mm 1

Recommended Management Approach

Surgical intervention is required for a 12mm stone 3, 4. The treatment options include:

Ureteroscopy (URS)

  • Stone-free rate of 93-94% for distal ureteral stones >10mm 2, 4
  • Stone-free rate of 78-86% for mid-ureteral stones >10mm 2, 4
  • Stone-free rate of 81% for proximal ureteral stones 4

Shock Wave Lithotripsy (SWL)

  • Stone-free rate of 74% for distal stones >10mm 2, 3
  • Stone-free rate of 76% for mid-ureteral stones >10mm 2, 3
  • Generally less effective than URS for stones of this size 2

Critical Pitfalls to Avoid

Do not attempt prolonged conservative management for a 12mm stone, as this exposes the patient to 1:

  • Risk of obstructive uropathy and potential renal damage
  • Increased risk of infection and urosepsis (0.6% sepsis rate even with appropriate stone sizes) 5
  • Unnecessary pain and decreased quality of life
  • Delayed definitive treatment

The stone location matters for surgical planning, but not for the decision to intervene—a 12mm stone requires surgery regardless of position (proximal, mid, or distal ureter) 2, 4.

Related Questions

For a woman with renal calyceal stones, when is tamsulosin appropriate and what are the preferred definitive treatment options?
Will white blood cell count (WBC) elevate with renal stones?
Can I take vitamin C and glutathione tablets together, and what doses are safe for a healthy adult?
How should I manage a patient with acute pulmonary embolism and deep‑vein thrombosis who presents with fever?
After relieving a urinary outflow obstruction (catheter placement, nephrostomy, ureteral stent, or surgical decompression), how long should the patient be monitored for post‑obstructive diuresis, what urine output thresholds define diuresis, and which risk factors (prolonged or bilateral obstruction, pre‑existing renal insufficiency, advanced age, pediatric age, comorbidities) necessitate extended monitoring?
How should a nipple laceration in a lactating patient be repaired, including anesthesia, suturing technique, tetanus prophylaxis, antibiotic coverage, and postoperative care?
In an adult with chronic prurigo nodularis refractory to high‑potency topical corticosteroids, intralesional steroids, antihistamines, moisturizers, and phototherapy, how should methotrexate be used (initial dose, titration, folic acid supplementation, laboratory monitoring, contraindications) and what alternative systemic therapies are available?
Why is activated charcoal contraindicated in patients with an unprotected airway (e.g., unconscious, GCS < 8, seizing, intoxicated, or unable to maintain protective reflexes)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.